Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
08/15/2013 | US20130210749 Peptides, constructs and uses therefor |
08/15/2013 | US20130210748 Method and peptide for regulating cellular activity |
08/15/2013 | US20130210745 Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles |
08/15/2013 | US20130210743 Peptidomimetic macrocycles |
08/15/2013 | US20130210741 Immunoregulatory peptides and methods of use |
08/15/2013 | US20130210740 Neo-tryptophan |
08/15/2013 | US20130210709 CXCR4 Receptor Compounds |
08/15/2013 | US20130210706 Dendrimeric peptides, pharmaceutical compositions and methods of using the same |
08/15/2013 | US20130210704 Novel cyclosporin derivatives and uses thereof |
08/15/2013 | US20130210144 Proteolytically resistant hydrogen bond surrogate helices |
08/15/2013 | US20130209551 Pentapeptide derivatives for promoting hair growth |
08/15/2013 | US20130209541 Il-13 receptor binding peptides |
08/14/2013 | EP2626364A1 Novel compounds |
08/14/2013 | EP2625192A1 A bioactive amino acid sequence and use therefrom |
08/14/2013 | EP2625191A1 A thermo-responsive polymer covalently bound with a peptide |
08/14/2013 | CN103249426A Methods and compositions comprising cyclic analogues of histatin 5 for treating wounds |
08/14/2013 | CN103242431A Preparation method of bivalirudin |
08/14/2013 | CN103242430A Angiotensin-converting enzyme inhibitory peptide, and preparation method and application thereof |
08/14/2013 | CN103242429A Simulation oligopeptide of vascular endothelial growth factor (VEGF) epitope and application of simulation oligopeptide |
08/14/2013 | CN103242428A Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same |
08/14/2013 | CN103242427A CTL epitope polypeptide of porcine reproductive and respiratory syndrome virus (PRRSV) and application thereof |
08/14/2013 | CN103242426A Avian influenza virus H5N1 subtype restrictive CTL epitope polypeptide and application thereof |
08/14/2013 | CN102584952B Antigen conformation epitope mimic peptide of hepatitis C virus F protein and application thereof |
08/14/2013 | CN102477075B Oligopeptide for resisting thrombi and preparation method and application thereof |
08/14/2013 | CN102229645B Method for preparing immune seven peptides |
08/14/2013 | CN101654475B Antigenic epitope of human tumor necrosis factor alpha and preparation method and application thereof |
08/13/2013 | US8507649 Cosmetic compositions comprising at least one peptide with at least one immobilized aromatic cycle |
08/13/2013 | US8507434 Peptide modulators of angiogenesis and use thereof |
08/13/2013 | US8507426 Peptides and related molecules that bind to TALL-1 |
08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
08/13/2013 | CA2410224C Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
08/08/2013 | WO2013113060A1 Peptide |
08/08/2013 | WO2013072813A3 Cytotoxic peptides and antibody drug conjugates thereof |
08/08/2013 | US20130205416 Anti-viral agent |
08/08/2013 | US20130203686 Azapeptides as cd36 binding compounds |
08/08/2013 | US20130203685 Protease targeting agents |
08/08/2013 | US20130203683 Immunoregulatory peptides and methods of use |
08/08/2013 | US20130203679 Immunoregulatory peptides and methods of use |
08/08/2013 | US20130203662 Mini-Hepcidin Peptides and Methods of Using Thereof |
08/08/2013 | US20130203654 Novel cyclic peptide compound, method for producing same, anti-infective agent, antibiotic-containing fraction, antibiotic, method for producing antibiotic, antibiotic-producing microorganism, and antibiotic produced by same |
08/08/2013 | US20130203649 Inhibitors of tlr signaling by targeting tir domain interfaces |
08/08/2013 | US20130203163 Promiscuous pap cd4 t cell epitopes |
08/08/2013 | US20130203060 Mammalian genes; related reagents |
08/08/2013 | US20130202634 Dengue Virus (DV) Polypeptide Sequences, T Cell Epitopes and Methods and Uses Thereof |
08/08/2013 | US20130202632 Minimal motifs of linear b-cell epitopes in l1 protein from human papillomavirus type 58 and their applications |
08/08/2013 | US20130202604 Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor |
08/08/2013 | DE112011103711T5 Caspofungin-Analogen Herstellungsverfahren dafür und Verwendung desselben The same caspofungin analogs manufacturing method thereof and use |
08/07/2013 | EP2623611A1 Method for purifying cyclic lipopeptide or salt thereof |
08/07/2013 | EP2623512A1 Peptide capable of binding to immunoglobulin |
08/07/2013 | EP2623511A1 Process for purifying cyclic lipopeptide compounds or salts thereof |
08/07/2013 | EP2623111A2 Peptides from the venom of the rhopalurus junceus scorpion and pharmaceutical composition |
08/07/2013 | EP2621941A1 Method for isolating a cyclohexapeptide |
08/07/2013 | EP2621537A1 Pentapeptide derivatives for promoting hair growth |
08/07/2013 | EP2621508A1 N-carboxyalkyl auristatins and the use thereof |
08/07/2013 | CN103237806A Peptide capable of binding to immunoglobulin |
08/07/2013 | CN103233012A Antioxidant peptide of odorrana andersonii skin and gene thereof |
08/07/2013 | CN103232531A Cancer cell-targeting structural molecule and use thereof |
08/07/2013 | CN103232530A Enramycin A and B separation method |
08/07/2013 | CN103232529A Epitope peptide |
08/07/2013 | CN103232381A Peptidomimetic protease inhibitors |
08/07/2013 | CN102380094B Application of specific polypeptide to preparation of rabies vaccine |
08/07/2013 | CN101880315B Branch oligopeptide with analgesic activity, preparation method and application thereof |
08/07/2013 | CN101679984B Rumc peptides with antimicrobial activity |
08/07/2013 | CN101389642B Cyclic antimicrobial peptides |
08/06/2013 | US8501911 Methods of reducing inflammation and mucus hypersecretion |
08/06/2013 | US8501691 Methods for treatment of headaches by administration of oxytocin |
08/06/2013 | US8501680 Antagonists against interaction of PF4 and RANTES |
08/06/2013 | CA2564179C Biologically active peptide vapeehptllteaplnpk derivatives |
08/06/2013 | CA2371929C Fab'-epitope complex from the hiv-1 cross-neutralizing monoclonal antibody 2f5 |
08/06/2013 | CA2238289C Biocontrol agent and fungicide for blackleg disease |
08/01/2013 | WO2013112548A1 Gamma-aapeptides with potent and broad-spectrum antimicrobial activity |
08/01/2013 | WO2013111129A1 Stabilized peptide helices for inhibiting dimerization of chemokine c motif receptor 2 (ccr2) |
08/01/2013 | WO2013111110A2 Synthetic apelin mimetics for the treatment of heart failure |
08/01/2013 | WO2013110790A1 Vaccine compositions for hiv prevention and treatment |
08/01/2013 | WO2013110120A1 Peptide agents for cancer therapy |
08/01/2013 | US20130196925 Compositions and methods useful in enhancement of memory |
08/01/2013 | US20130196922 Bnip3 isoforms and methods of use |
08/01/2013 | US20130196902 Beta-Arrestin Effectors and Compositions and Methods of Use Thereof |
08/01/2013 | US20130196899 Synthetic apelin mimetics for the treatment of heart failure |
08/01/2013 | US20130196896 Car peptide for homing, diagnosis & targeted therapy for pulmonary and fibrotic disorders |
08/01/2013 | US20130195909 Composite Antigenic Sequences and Vaccines |
08/01/2013 | US20130195901 Ssx-2 peptide analogs |
08/01/2013 | US20130195860 Antibody targeting through a modular recognition domain |
08/01/2013 | DE102011118031B4 Calicivirus bindende Peptide, dafür kodierende Nukleinsäuren, deren Verwendungen und Verfahren und Kits zur Anreicherung, Immobilisierung und zum Nachweis von Caliciviren Calicivirus binding peptides, nucleic acids encoding, uses thereof and methods and kits for enrichment, immobilization and detection of caliciviruses |
08/01/2013 | CA2862485A1 Peptide agents for cancer therapy |
07/31/2013 | EP2620445A1 Polypeptide tf1 for inhibiting type 2 shiga toxin activity, encoding gene for same and use thereof |
07/31/2013 | EP2619218A2 Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof |
07/31/2013 | EP2618808A1 Cosmetic use of dermicidin, and analogues or fragments thereof |
07/31/2013 | CN1910198B Tumor antigens for prevention and/or treatment of cancer |
07/31/2013 | CN103224898A Marine bacillus and its polypeptide with antitumor activity |
07/31/2013 | CN103224548A Polypeptide for preparing cattle foot-and-mouth disease ASIAI type peptide vaccine and preparing method and use thereof |
07/31/2013 | CN103224547A Daptomycin separation and purification method |
07/31/2013 | CN103224495A Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
07/31/2013 | CN102659926B Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
07/31/2013 | CN102584949B Pc-C polypeptide inhibiting aspergillus fumigatus from adhering to cornea |
07/31/2013 | CN102351949B Xenorhabdus antibacterial peptide and application thereof in inhibiting growth of pathogenic fungi and bacteria |
07/31/2013 | CN102336814B Polypeptide sequence for preparing anti-liver-neoplasm marker CK-19 antibody, polyclonal antibody and application thereof |
07/31/2013 | CN102040653B Tag peptide capable of realizing affinity binding with polystyrene and method for preparing enzyme-linked immuno solid phase antigen with same |
07/30/2013 | US8497352 Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer |
07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |